Mary Redman PhD

Mary Redman earned her Ph.D. in Biostatistics at the University of Washington in 2004 and joined Fred Hutch in 2005. She has extensive experience in designing, monitoring, and analyzing cancer clinical trials. She is the lead statistician for the Lung Committee and the Lung-MAP trial in SWOG. She has worked at least 50-60 Phase I, II, and III clinical trials in lung, other solid tumor cancers, and sarcoma and lymphoma. Her area of focus is on a clinical trial design incorporating potentially predictive biomarkers.